OTCMKTS:ICOTF iCo Therapeutics (ICOTF) Stock Forecast, Price & News $0.43 0.00 (0.00%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$0.43▼$0.4650-Day Range$0.27▼$0.5652-Week Range$0.80▼$1.82Volume6,086 shsAverage Volume4,760 shsMarket Capitalization$3.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About iCo Therapeutics (OTCMKTS:ICOTF) StockSatellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.Read More Receive ICOTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ICOTF Stock News HeadlinesMay 10, 2023 | wsj.comICO Group Ltd.February 25, 2023 | marketwatch.comAntisense & RNAi Therapeutics Market 2023 Estimated to Perceive Exponential Growth till 2028June 2, 2023 | Behind the Markets (Ad)[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>February 19, 2023 | finance.yahoo.comWomen's health therapeutics market size to increase by USD 30.35 billion: North America to account for 37% of market growth - TechnavioFebruary 19, 2023 | seekingalpha.comJasper Therapeutics releases promising early-stage data on sickle cell disease treatmentOctober 10, 2022 | usnews.comConsumers to Ditch Cafes for Coffee at Home Amid Rising Prices, Says ICOAugust 16, 2022 | investing.comSatellos Bioscience Inc (MSCL)June 1, 2022 | seekingalpha.comSatellos Bioscience GAAP EPS of -C$0.06June 2, 2023 | Behind the Markets (Ad)[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>December 16, 2021 | finance.yahoo.comSatellos Bioscience Inc. Announces Scientific Research Agreement with Université de Sherbrooke to Study Rare Muscular DystrophiesDecember 15, 2021 | finance.yahoo.comSatellos Bioscience to Webcast Live at Life Sciences Investor Forum December 16thDecember 9, 2021 | finance.yahoo.comICOTF: Targeting Stem Cells for Muscular Dystrophy TreatmentDecember 6, 2021 | finance.yahoo.comSatellos Bioscience Announces New Board AppointmentsDecember 2, 2021 | investing.comiCo Therapeutics Inc (MSCL)November 29, 2021 | finance.yahoo.comSatellos Bioscience Reports Third Quarter 2021 Financial Results and Operational HighlightsOctober 27, 2021 | finance.yahoo.comSatellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations ServicesAugust 5, 2021 | finance.yahoo.comiCo Therapeutics Inc. Announces Shareholder Approval of Business Combination with Satellos Bioscience Inc.July 15, 2021 | stockhouse.comiCo Therapeutics Inc. V.ICOJuly 9, 2021 | finance.yahoo.comiCo Therapeutics Inc. Announces TSX Venture Exchange Conditional Approval and Provides Update Regarding Business Combination with Satellos Bioscience Inc.June 2, 2021 | finanznachrichten.deiCo Therapeutics Inc.: iCo Therapeutics Announces First Quarter 2021 Financial ResultsMay 11, 2021 | finance.yahoo.comiCo Therapeutics Subsidiary to present Oral Amphotericin B / SARS-Cov-2 Research Results at National Pharmaceutical Sciences MeetingApril 29, 2021 | finance.yahoo.comiCo Therapeutics Announces 2020 Year End Financial Results and Resignation of Susan KoppyApril 27, 2021 | finance.yahoo.comiCo Therapeutics Inc. Announces Closing of Upsized Subscription Receipt Private PlacementApril 23, 2021 | finance.yahoo.comiCo Therapeutics Inc. Announces Upsized Subscription Receipt Private PlacementMarch 22, 2021 | finance.yahoo.comiCo Therapeutics Inc. Agrees to a Business Combination with Satellos Bioscience Inc.March 12, 2021 | finance.yahoo.comiCo Therapeutics Inc. Announces Warrant ExercisesFebruary 25, 2021 | finance.yahoo.comIIROC Trading Halt - ICOSee More Headlines ICOTF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICOTF Company Calendar Today6/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical Preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ICOTF CUSIPN/A CIKN/A Webwww.icotherapeutics.com Phone(905) 336-6128Fax604-602-9699EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,110,000.00 Net MarginsN/A Pretax Margin-4,148.78% Return on EquityN/A Return on Assets-288.85% Debt Debt-to-Equity RatioN/A Current Ratio0.72 Quick Ratio0.72 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-6.13Miscellaneous Outstanding Shares9,054,000Free FloatN/AMarket Cap$3.89 million OptionableNot Optionable Beta2.03 Key ExecutivesFrank GleesonPresident & Chief Executive OfficerWarren WhiteheadChief Financial OfficerMichael RudnickiChief Scientific OfficerJ. Robert HallVice President-Finance & AdministrationKey CompetitorsAgile TherapeuticsNASDAQ:AGRXTransCode TherapeuticsNASDAQ:RNAZHistogenNASDAQ:HSTODermata TherapeuticsNASDAQ:DRMAFirst Wave BioPharmaNASDAQ:FWBIView All Competitors ICOTF Stock - Frequently Asked Questions How have ICOTF shares performed in 2023? iCo Therapeutics' stock was trading at $0.1716 on January 1st, 2023. Since then, ICOTF shares have increased by 150.2% and is now trading at $0.4293. View the best growth stocks for 2023 here. What is iCo Therapeutics' stock symbol? iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF." How do I buy shares of iCo Therapeutics? Shares of ICOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iCo Therapeutics' stock price today? One share of ICOTF stock can currently be purchased for approximately $0.43. How much money does iCo Therapeutics make? iCo Therapeutics (OTCMKTS:ICOTF) has a market capitalization of $3.89 million. The biotechnology company earns $-1,110,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis. How can I contact iCo Therapeutics? iCo Therapeutics' mailing address is 777 Hornby Street 6th Floor, Vancouver A1, V6Z 2T3. The official website for the company is www.icotherapeutics.com. The biotechnology company can be reached via phone at (905) 336-6128, via email at liggett@icotherapeutics.com, or via fax at 604-602-9699. This page (OTCMKTS:ICOTF) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.